ReviewFrontiers in neuroscience2022

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Niklas Reich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.